HIT Consultant September 16, 2021
Jasmine Pennic

What You Should Know:

– Today, Rune Labs, founded by the former head of Google neuroscience, announced a $22.8M Series A round for the development and delivery of precision medicine for neurodegenerative and psychiatric disorders and diseases like dementia, Alzheimer’s, and Parkinson’s, as well as neurological conditions resulting from COVID infections. The round was led by Eclipse Ventures with participation from current investors including DigiTx and Moment Ventures. Justin Butler, Partner at Eclipse, will join the Rune Labs Board of Directors.

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Investments, Pharma / Biotech, Precision Medicine, Trends
23andMe: What If …
23andMe CEO Anne Wojcicki considers taking company private
Age of Opportunity: Artificial Intelligence and the Precision Medicine Future
Opinion: Readers respond to OTC antidepressants, personalized medicine, restoring trust in public health, and more
Precision medicine approach combining AI, DNA and drug testing shows gains against relapsed childhood cancers

Share This Article